Reproductive Genetics Market Report 2026

Reproductive Genetics Market Overview

• Reproductive Genetics market size has reached to $7.91 billion in 2025 • Expected to grow to $16.22 billion in 2030 at a compound annual growth rate (CAGR) of 15.4% • Growth Driver: Rising Prevalence Of Genetic Disorders Is Fueling The Growth Of The Market Due To Increasing Demand For Early Detection And Informed Reproductive Choices • Market Trend: Technological Innovations In Embryo Selection Are Transforming Personalized Reproductive Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Reproductive Genetics Market?

Reproductive genetics is a branch of genetics that studies how genetic factors influence reproduction and the transmission of hereditary traits. It focuses on the genetic makeup of individuals involved in reproduction, examining how genes and chromosomes affect fertility, conception, and the development of an embryo. This field explores the role of inherited genetic variations and their impact on reproductive health, aiming to enhance understanding of the biological processes involved in human reproduction and heredity. The main product types of reproductive genetics are kits, laboratory-developed tests (LDT), and reagents and consumables. Kits refers to the offspring or young born from a single reproductive event and is commonly used to describe the litters of animals such as rabbits or ferrets. It uses different technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), in-situ hybridization (ISH), and microarray analysis and is applied for aneuploidy, single gene disorder, structural chromosomal abnormality, and others. It is used by several end users, such as hospitals, diagnostic laboratories, fertility clinics, and research institutions.

What Is The Reproductive Genetics Market Growth Forecast?

The reproductive genetics market size is expected to see rapid growth in the next few years. It will grow to $16.22 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to growing adoption of precision reproductive medicine, rising investments in fertility genomics research, expansion of non-invasive prenatal testing, increasing use of ai-driven genetic interpretation, advancements in sequencing accuracy and affordability. Major trends in the forecast period include increasing adoption of preimplantation genetic testing, rising demand for carrier screening solutions, growing use of ngs-based reproductive diagnostics, expansion of personalized fertility treatment planning, enhanced integration of laboratory automation.

Global Reproductive Genetics Market Segmentation

1) By Product Type: Kits, Laboratory Developed Tests (LDT), Reagents And Consumables 2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In-Situ Hybridization (ISH), Microarray Analysis 3) By Application: Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Other Applications 4) By End User: Hospitals, Diagnostic Laboratories, Fertility Clinics, Research Institutions Subsegments: 1) By Kits: Sample Collection Kits, Extraction Kits, Amplification Kits, Sequencing Kits, Hybridization Kits 2) By Laboratory Developed Tests: Carrier Screening Tests, Preimplantation Genetic Tests, Prenatal Diagnostic Tests, Aneuploidy Detection Tests, Single Gene Disorder Tests 3) By Reagents And Consumables: Enzymes, Buffers, Probes, Fluorescent Labels, Laboratory Plasticware

What Is The Driver Of The Reproductive Genetics Market?

The increasing number of genetic disorders is expected to propel the growth of the reproductive genetics market going forward. Genetic disorders refer to diseases caused by abnormalities in an individual's deoxyribonucleic acid (DNA), ranging from a single gene mutation to chromosomal defects. The rise in genetic disorders is due to reproductive genetic testing, as families seek early insights that reduce uncertainty, support informed reproductive choices, and help prevent the transmission of inherited conditions. Reproductive genetics is essential for detecting and managing genetic disorders, helping families make informed decisions, and reducing the risk of passing conditions to future generations. For instance, in July 2024, according to Cystic Fibrosis Australia, an Australia-based national consumer body, the number of people with Cystic Fibrosis (CF) in the Australian Cystic Fibrosis Data Registry (ACFDR) rose from 3,738 in 2022 to 3,798 in 2023, a 1.6% increase. Therefore, the increasing number of genetic disorders is expected to propel the growth of the reproductive genetics industry.

Key Players In The Global Reproductive Genetics Market

Major companies operating in the reproductive genetics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Medicover AB, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., The Cooper Companies Inc., Vitrolife AB, BillionToOne Inc., Sophia Genetics SA, Eurofins Genomics India Private Limited, Invitae Corporation, Igenomix, Gonagen GmbH, Darwin AG.

Global Reproductive Genetics Market Trends and Insights

Major companies operating in the reproductive genetics market are focusing on developing advanced solutions, such as comprehensive multi-trait embryo comparison, to enable more precise, data-driven, and personalized embryo selection for IVF patients. Comprehensive multi-trait embryo comparison refers to an analytical approach that evaluates multiple embryos simultaneously across hundreds of hereditary conditions and complex traits using genomic and polygenic scoring, allowing prospective parents to make more informed choices during in vitro fertilization. For instance, in June 2025, Nucleus Genomics Inc., a US-based biotechnology company, launched Nucleus Embryo, a reproductive genetics platform that allows patients to analyze and compare up to 20 embryos across more than 900 inherited conditions, incorporating polygenic scoring for complex traits such as appearance, cognitive ability, and mental health, and offering a comprehensive, multi-trait comparison interface that significantly expands embryo-selection capabilities beyond traditional screening methods.

What Are Latest Mergers And Acquisitions In The Reproductive Genetics Market?

In January 2024, Natera Inc., a US-based genetic testing and diagnostics company, acquired health assets from Invitae Corporation for $52.5 million. Through this acquisition, Natera aims to expand its reproductive genetics services by integrating Invitae’s non-invasive prenatal screening and carrier screening business to better serve patients and healthcare providers. Invitae Corporation is a US-based genetic information company that provides reproductive genetics services, including preimplantation genetic testing, carrier screening, and miscarriage analysis.

Regional Outlook

North America was the largest region in the reproductive genetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Reproductive Genetics Market?

The reproductive genetics market consists of revenues earned by entities by providing services such as infertility genetic testing, genetic counselling, genomic data interpretation, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The reproductive genetics market also includes sales of cryopreservation media, embryo biopsy tools, and lab information management systems (LIMS). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Reproductive Genetics Market Report 2026?

The reproductive genetics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the reproductive genetics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.